品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R030811-10mg | 10mg | 5~7个工作日 | 402957-28-2 |
Telaprevir Telaprevi |
98% |
|
|
罗恩 | R030811-50mg | 50mg | 5~7个工作日 | 402957-28-2 |
Telaprevir Telaprevi |
98% |
|
|
罗恩 | R030811-5mg | 5mg | 5~7个工作日 | 402957-28-2 |
Telaprevir Telaprevi |
98% |
|
|
阿拉丁 | T126775-5mg | 5mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿拉丁 | T126775-10mg | 10mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿拉丁 | T126775-50mg | 50mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿拉丁 | T423845-1ml | 1ml | 现货 | 402957-28-2 |
Telaprevir Telaprevi |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | T126775-100mg | 100mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿拉丁 | T126775-250mg | 250mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿拉丁 | T126775-25mg | 25mg | 现货 | 402957-28-2 |
特拉匹韦 Telaprevi |
Moligand™, ≥98% |
|
|
阿法埃莎 | C46689-1GR | 1GR | 现货 | 402957-28-2 |
Telaprevir Telaprevi |
|
|
|
阿法埃莎 | C46689-250MG | 250MG | 现货 | 402957-28-2 |
Telaprevir Telaprevi |
|
|
|
毕得 | BD167186-1mg | 1mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-5mg | 5mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-10mg | 10mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-25mg | 25mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-50mg | 50mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-100mg | 100mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-250mg | 250mg | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|
毕得 | BD167186-1g | 1g | 现货 | 402957-28-2 |
(1S,3aR,6aS)-2-((S)-2-((S)-2... (1S,3aR,6aS)-2-((S)-2-((S)-2... |
97% |
|
|